Abstract
Psoriasis Area and Severity Index(PASI) scoring was initially developed by Fredriksson and Pettersson in 1978[1], as a method to clinically evaluate and quantitate the amount and severity of psoriasis, and therefore the responses to a new treatment. Despite its advantages, there are numerous limitations such as high intra- and inter-observer variability and reproducibility in assessment of each of the PASI parameters[2], with scores varying two or three fold between scorers[2-5]. This article is protected by copyright. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | e352–e353 |
Number of pages | 2 |
Journal | Journal of the European Academy of Dermatology and Venereology |
Volume | 31 |
Issue number | 8 |
Early online date | 6 Feb 2017 |
DOIs | |
Publication status | Published - Aug 2017 |